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INTRODUCTION

DISCUSSION

Spinal Cord Stimulation (SCS) is an effective therapeutic option for patients
suffering from chronic pain syndromes, who have not obtained relief from more
conservative measures. A potential complication associated with percutaneous
SCS insertion includes dural puncture and cerebrospinal fluid (CSF) leakage.
This complication can lead to postdural puncture headache (PDPH) and pose a
challenge during SCS trials and implantation. Epidural blood patching is an
effective treatment for PDPH. Our goal is to explore the role of epidural blood
patches during SCS procedure, if a CSF leak is identified.

Dural puncture is a well recognized possible complication following spinal cord
stimulator procedures. The incidence for this complication has been reported to
be 0.3-7% in prior studies2,3,5. We observed this complication in 2% of the
patients undergoing SCS procedures. The management of patients with a CSF
leak remains controversial. Previous suggestions include removing the leads
and attempting SCS placment at a later date or delaying programming of the
SCS until the PDPH has resolved4. In patients underoing spinal cord simulator
trials, post-dural puncture pain could make it difficult to assess the efficacy of
the spinal cord stimulator. One possible cause may be abberrant electrical
conduction from the SCS because of the CSF leak3. Delayed treatment of a
CSF leak may lead to PDPH and failure of the trial. This challenge has
significant clinical and economic implications for the patient. Furthermore, it is
important to identify patients who are at a greater risk for dural puncture prior
to SCS procedures. In our study, one of the patients who experienced a dural
puncture and CSF leak had a significant history of prior lumbar surgeries,
increasing the potential for fibrosis and scarring. Pre-operative imaging to
identify fibrosis might lead to prevention of dural punctures in these patients.

STUDY DESCRIPTION
A retrospective chart review was performed to identify patients who underwent
SCS trials or permanent implantation from 2005 to 2010 at an academic and
private outpatient surgical center. Of the 285 SCS procedures (160 trials, 125
permanent implantation), a total of 7 patients (3 males, 4 females) were found to
have a CSF leak intra-operatively. Their ages ranged from 44 to 72 (average:
54). The level of leak was identified as T6-7 for 1 patient, and T11- 12 for the
other 6 patients. 5 of these patients underwent an epidural blood patch to the
contra-lateral side intra-operatively,
after the SCS lead was appropriately
inserted. 2 of the patients did not receive an intra-operative blood patch and
were monitored for symptoms.

Figure 1: Placement of Thoracic SCS leads in a
patient with previous Lumbar SCS leads.

CONCLUSION
Our data is consistent with prior studies in demonstrating that the incidence of
dural puncture and CSF leak with SCS procedures is rare. Based on our
experiences, performing an epidural blood patch intra-operatively on the
contra-lateral side under fluoroscopy could prevent PDPH. This treatment
should especially be considered in patients underoing SCS trials in order to
accurately assess the level of pain reduction. Patients with prior spine
surgeries might pose higher risks for dural puncture and more extensive preoperative assessment could be beneficial.

RESULTS
All five patients treated intra-operatively with an epidural blood patch sustained
significant pain relief after the SCS trial or implantation. These patients did not
experience any symptoms consistent with PDPH during the post-operative period.
One of the five patients had a history of multiple lumbar surgeries in the past
along with lumbar SCS placement for chronic refractory lower back and leg pain.
This patient underwent thoracic SCS implantation for upper back pain which was
not covered by lumbar SCS. This patient’s CSF leak was treated with a contralateral epidural blood patch intra-operatively. He sustained significant pain relief
from the permanent SCS implanted without symptoms of headache. The two
patients who did not receive an intra-operative blood patch developed symptoms
consistent with PDPH post-operatively. One of the patients was treated with
conservative measures and her symptoms resolved. The second patient failed
conservative treatment and received an epidural blood patch 1 week later. This
patient had less than 50% reduction in her regular pain during the trial and
therefore no permanent implantation was performed.
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Figure 2: Contrast illustrating correct needle
position prior to epidural blood patch at T6-T7
during spinal cord stimulator trial
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